(Q84396538)
Statements
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study (English)
F Sangalli
L Moiola
S Bucello
A Rizzo
M Radaelli
G Vitello
L M E Grimaldi
A Ghezzi
V Martinelli
1 reference
1 reference